Hepatitis Clinical Trials in San Antonio

Showing 261-280 of 280 trials

Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy

NCT00120861

This study is being conducted to compare the safety, effectiveness and tolerance of valopicitabine (NM283) when used alone and when valopicitabine is used together with pegylated interferon in hepatitis C treatment failure patients. These results will be compared against the results of treatment with pegylated interferon plus ribavirin, the current standard therapy for treatment of hepatitis C viral infection.

Chronic Hepatitis C

Merck Sharp & Dohme LLCStarted Jan 2005

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +8 more locations

COMPLETEDPhase 1/2< 1 mile

Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C

NCT00120835

This study is being conducted in treatment-naive patients (no previous hepatitis C treatment) to evaluate the safety of valopicitabine (NM283) alone and together with pegylated interferon, a drug approved by the Food and Drug Administration for the treatment of hepatitis C infection. This study is also evaluating the ability of valopicitabine to decrease the amount of hepatitis C virus in the body. The results for patients taking valopicitabine alone will be compared with the results for patients taking valopicitabine together with pegylated interferon.

Chronic Hepatitis C

Merck Sharp & Dohme LLCStarted Jul 2004

Bradenton, Florida, United States • San Antonio, Texas, United States • Santurce, Puerto Rico

COMPLETEDPhase 1< 1 mile

A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

NCT00703469

This study examines the safety, tolerability, and immunogenicity of a single dose of MDX-1106 in patients with active hepatitis C genotype 1 or mixed hepatitis C genotype infection.

Hepatitis C

Bristol-Myers Squibb54 participantsStarted Oct 2008

Anaheim, California, United States • San Francisco, California, United States • Springfield, Illinois, United States +4 more locations

Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy

Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C

A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

Hepatitis Trials in Other Cities

Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)

Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection

Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus

Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus

A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C

Reducing Depressive Symptoms During HCV Therapy: A Randomized Study

Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9

Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection

A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus

PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients

Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

Other Conditions in San Antonio